Chunlai Y. Feng
No.301 Xuefu Road
Zhenjiang, 212013, China
Zhenjiang, 212013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Diagnostic value of pentraxin 3 in plasma and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients: a prospective multicenter clinical study.
Journal: Emerging microbes & infections
Published: April 29, 2026
6-Shogaol attenuates liver fibrosis by driving hepatic stellate cell senescence through the cGAS-STING-NF-κB axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 14, 2026
Development and external validation of a machine learning model for predicting tigecycline-associated drug-induced liver injury.
Journal: iScience
Published: February 02, 2026
Rehmannioside A Attenuates Inflammation via Inactivation of the p-p65 NF-?B and p-p38 MAPK Signaling in Abdominal Infection-Induced Acute Kidney Injury.
Journal: Physiological research
Published: December 17, 2025
The clinical value of metagenomic next generation sequencing in the diagnosis of non-neutropenic invasive pulmonary aspergillosis.
Journal: Frontiers in cellular and infection microbiology
Published: October 24, 2025
Case Report: pembrolizumab monotherapy achieves durable disease control in a patient with BRAF V600E-mutant advanced lung adenocarcinoma and high PD-L1 expression intolerant to BRAF/MEK inhibition.
Journal: Frontiers in oncology
Published: October 08, 2025
Clinical diagnostic value of targeted next generation sequencing for lower respiratory tract infection: a retrospective study.
Journal: Frontiers in cellular and infection microbiology
Published: September 26, 2025
Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis.
Journal: Microbiology spectrum
Published: September 09, 2025
Rational Design of a Bioconjugated Antitumor Peptide with Tumor-Selective Targeting and Microenvironment-Responsive Activation.
Journal: Pharmaceutical research
Published: July 27, 2025
Discovery of Small-Molecule PD-L1 Inhibitors via Virtual Screening and Their Immune-Mediated Anti-Tumor Effects.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 15, 2025
pH-responsive polymeric nanoparticles for peptide delivery: Synergistic STING pathway activation enhances tumor immunotherapy.
Journal: International journal of pharmaceutics: X
Published: July 07, 2025
Last Updated: 09/26/2026